Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Human Cytomegalovirus (HCMV) Mother-to-fetus Transmission by Administration of Virus-specific Hyperimmune Globulin to Pregnant Women With Primary HCMV Infection

NCT00881517 is registered in ClinicalTrials.gov with Fondazione IRCCS Policlinico San Matteo di Pavia as lead sponsor.

NCT NCT00881517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00881517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Human Cytomegalovirus (HCMV) Mother-to-fetus Transmission by Administration of Virus-specific Hyperimmune Globulin to Pregnant Women With Primary HCMV Infection
Lead sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2009
Completion date
October 31, 2011
Enrollment
124 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infection